FI903834A0 - Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiokarbamat och deras derivat. - Google Patents

Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiokarbamat och deras derivat.

Info

Publication number
FI903834A0
FI903834A0 FI903834A FI903834A FI903834A0 FI 903834 A0 FI903834 A0 FI 903834A0 FI 903834 A FI903834 A FI 903834A FI 903834 A FI903834 A FI 903834A FI 903834 A0 FI903834 A0 FI 903834A0
Authority
FI
Finland
Prior art keywords
framstation
thiocarbamate
butynyl
derivatives
procedure
Prior art date
Application number
FI903834A
Other languages
English (en)
Inventor
Stephen Clark Bergmeier
Jeffrey Alan Kester
Walter Hamilton Moos
Haile Tecle
Anthony Jerome Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI903834A0 publication Critical patent/FI903834A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI903834A 1989-08-02 1990-08-01 Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiokarbamat och deras derivat. FI903834A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,777 US4996201A (en) 1989-08-02 1989-08-02 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents

Publications (1)

Publication Number Publication Date
FI903834A0 true FI903834A0 (fi) 1990-08-01

Family

ID=23535470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903834A FI903834A0 (fi) 1989-08-02 1990-08-01 Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiokarbamat och deras derivat.

Country Status (11)

Country Link
US (1) US4996201A (fi)
EP (1) EP0411616A1 (fi)
JP (1) JPH0374376A (fi)
KR (1) KR910004550A (fi)
AU (1) AU6001890A (fi)
CA (1) CA2022511A1 (fi)
FI (1) FI903834A0 (fi)
IE (1) IE902791A1 (fi)
NO (1) NO903386L (fi)
PT (1) PT94873A (fi)
ZA (1) ZA906056B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5468875A (en) * 1994-12-22 1995-11-21 American Home Products Corporation 1-azabicycloheptane derivatives
US5668144A (en) * 1995-11-08 1997-09-16 American Home Products Corporation 1-azabicyclopheptane derivatives
US5773458A (en) * 1996-10-30 1998-06-30 American Home Products Corporation 1-azabicycloheptane derivatives
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
EP1604686A1 (en) * 2004-06-08 2005-12-14 Axonyx, Inc. Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131213A (en) * 1957-05-21 1964-04-28 Sterling Drug Inc 2, 6-dimethyl and 2, 6-diethylphenyl n-(aminoalkyl) carbamates and acid addition salts thereof
US4065471A (en) * 1965-04-09 1977-12-27 Sterling Drug Inc. N-(4-Amino-2-butynyl)imides
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
US3452031A (en) * 1967-07-21 1969-06-24 Parke Davis & Co Aminoalkylcarbamate esters
DE2515146A1 (de) * 1975-04-08 1976-10-21 Bayer Ag Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IE902791A1 (en) 1991-02-27
JPH0374376A (ja) 1991-03-28
ZA906056B (en) 1992-04-29
US4996201A (en) 1991-02-26
NO903386D0 (no) 1990-08-01
EP0411616A1 (en) 1991-02-06
AU6001890A (en) 1991-02-07
KR910004550A (ko) 1991-03-28
CA2022511A1 (en) 1991-02-03
NO903386L (no) 1991-02-04
PT94873A (pt) 1991-04-18

Similar Documents

Publication Publication Date Title
FI921997A (fi) N-(1-(2-karboxietyl)cykloalkyl- karbonyl)beta-alaninderivat foer farmaceutiskt bruk.
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
FI905444A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
DK654589A (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
NO307340B1 (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-[4-(1,1-dioksido-3- okso-2,3-dihydro-benzisotiazol-2-yl)-butyl]-aminometyl}-kroman, legemiddel inneholdende samme, samt fremstilling og anvendelse av samme
IS4718A (is) (-) cis-6(S)-fenýl-5(R)-[4-(2-pýrrólidín-1-ýl-etoxý)fenýl]-5,6,7,8-tetrahýdrónaftalen-2-ól-D-tartrat, notkun, lyfjablanda og framleiðsla hennar
FI962445A (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
NO923283D0 (no) 1,4-benzodioksanderivater, fremgangsmaate for fremstillingderav, samt farmasoeytiske preparater som inneholder minstett slikt derivat
NO180678C (no) N-substituerte heterocykliske forbindelser og farmasöytisk preparat
MX9203505A (es) N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos.
FI952324A (fi) Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet
FI103883B1 (fi) Menetelmä dialkyyli-2,3-pyridiinidikarboksylaatin ja sen johdannaisten valmistamiseksi dialkyylidikloorisukkinaatista
FI903834A0 (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiokarbamat och deras derivat.
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI931033A0 (fi) Foerfarande foer framstaellning av dialkyl-2,3-pyridindikarboxylat och derivat daerav ur a,b-omaettade oximer och aminobutendioat
DK448885D0 (da) Pyridyloxyderivater og medicinsk acceptable salte, hydrater og solvater heraf samt farmaceutisk produkt omfattende samme
NO934032D0 (no) Fremgangsmaate for fjerning av allergeniske forbindelser fra en proteinblanding, et saaledes erholdt produkt, og anvendelse derav
EP0650723A3 (en) New pharmaceutical uses of forskolin derivatives.
BR9202327A (pt) Composto heterociclico,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
NZ239186A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
NO901732D0 (no) Fremgangsmaate for fremstilling av 4-alkoksyalkyl-4-aminofenylpiperidiner og derivater derav.
FI950575A (fi) 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen
NZ235455A (en) 2-(1,3-dioxan-2-yl)-4,5-diphenylimidazole derivatives and pharmaceutical compositions
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY